Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow in Hematology-Oncology, Medicine, Tufts University 1992 - 1994
  • Fellow in Hematology-Oncology, Medicine, Brown University 1990 - 1992
  • Medical Resident, Medicine, Brown University 1986 - 1989
  • M.D., Vanderbilt University 1986
  • Ph.D., University of California at Irvine 1983
• 

  Duke Appointment History

  • Associate Professor of Medicine, Medicine, Medical Oncology, Medicine 2014 - 2016
  • Associate Professor of Medicine, Medicine, Medical Oncology, Medicine 2010 - 2014
  • Assistant Professor of Medicine, Medicine, Medical Oncology, Medicine 2006 - 2010
  • Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 2006
• Research
• 

  Selected Grants

  • B9991023 awarded by Pfizer, Inc. 2018 - 2023
  • M16-300 awarded by AbbVie Inc. 2017 - 2022
  • M16-298 (MERU) awarded by AbbVie Inc. 2017 - 2022
  • BMS CA209817 awarded by Bristol-Myers Squibb Company 2017 - 2021
  • TOP 1501 awarded by Merck 2016 - 2021
  • BMS451 awarded by Bristol-Myers Squibb Company 2016 - 2021
  • TRINITY awarded by Stem CentRx, Inc. 2016 - 2021
  • CheckMate 568 awarded by Bristol-Myers Squibb Company 2016 - 2021
  • Condor awarded by AstraZeneca LP 2015 - 2020
  • BMS CA 209-331-001 An Open label, Randomized Phase 3 Study of Nivolumab or Chemo awarded by The Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership 2015 - 2020
  • A phase II, multi-center, single-arm, global study of MEDI4736 monotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) awarded by AstraZeneca Pharmaceuticals, LP 2015 - 2020
  • An open label, randomized phase 3 clincal trial of Nivolumab vs therapy of investigator's choice in recurrent or metasti awarded by Bristol-Myers Squibb Company 2014 - 2020
  • BMS PROTOTYPE LUNG PROGRAM - 3 DAY PROGRAMMING awarded by Bristol-Myers Squibb Company 2018 - 2019
  • A phase 1 / 2 multicenter study of BMS-986012 in subjects with relapsed/refractory small cell lung cnacer awarded by Bristol-Myers Squibb Company 2014 - 2019
  • An open-label, randomized, phase 3 trial of Nivolumab vs Investigator's choice chemotherapy as first-line therapy ofr st awarded by Bristol-Myers Squibb Company 2014 - 2018
  • A phase II, multicenter, single-arm study of MPDL3280A in patients with advanced PD-L1_positive Locally advanced or Meta awarded by Genentech, Inc. 2013 - 2018
  • Evaluation of Tumor Infiltrating Lymphocytes in Resected Non Small Cell Lung Cancer awarded by Lung Cancer Initiative of North Carolina 2015 - 2018
  • A Phase I study to evaluate the saftey, phamocokinetics and pharmacodynamics of JNJ-42756493 a pan-fibroblat growth fact awarded by Janssen Research & Development, LLC 2014 - 2018
  • AFT_31_ALLIANCE FOUNDATION TRIAL awarded by Alliance Foundation Trials, LLC 2017 - 2018
  • BMS-227 awarded by Bristol-Myers Squibb Company 2015 - 2018
  • Phase I/II open label dose escalation study of the safety, pharmacokinetics, and preliminary efficacy of SCI6D6.5 as a s awarded by Stem CentRx, Inc. 2013 - 2018
  • Abbvie M14-361 awarded by AbbVie Inc. 2015 - 2017
  • Programs in Clinical Effectiveness of Cancer Pharmacogenomics awarded by National Institutes of Health 2009 - 2012
  • Refining and Validating Genomic Signatures in Lung Cancer awarded by National Institutes of Health 2009 - 2010
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Khoury, T, Jang, D, Carrau, R, Ready, N, Barak, I, and Hachem, RA. "Role of induction chemotherapy in sinonasal malignancies: a systematic review." International Forum of Allergy & Rhinology 9, no. 2 (February 2019): 212-219. (Review)  Full Text
    • Ready, N, Farago, AF, de Braud, F, Atmaca, A, Hellmann, MD, Schneider, JG, Spigel, DR, Moreno, V, Chau, I, Hann, CL, Eder, JP, Steele, NL, Pieters, A, Fairchild, J, and Antonia, SJ. "Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 14, no. 2 (February 2019): 237-244.  Full Text
    • Zandberg, DP, Algazi, AP, Jimeno, A, Good, JS, Fayette, J, Bouganim, N, Ready, NE, Clement, PM, Even, C, Jang, RW, Wong, S, Keilholz, U, Gilbert, J, Fenton, M, Braña, I, Henry, S, Remenar, E, Papai, Z, Siu, LL, Jarkowski, A, Armstrong, JM, Asubonteng, K, Fan, J, Melillo, G, and Mesía, R. "Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy." European Journal of Cancer (Oxford, England : 1990) 107 (January 2019): 142-152.  Full Text
    • Liu, SV, Camidge, DR, Gettinger, SN, Giaccone, G, Heist, RS, Hodi, FS, Ready, NE, Zhang, W, Wallin, J, Funke, R, Waterkamp, D, Foster, P, Iizuka, K, and Powderly, J. "Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non-small-cell lung cancer." European Journal of Cancer (Oxford, England : 1990) 101 (September 2018): 114-122.  Full Text
    • Vokes, EE, Ready, N, Felip, E, Horn, L, Burgio, MA, Antonia, SJ, Arén Frontera, O, Gettinger, S, Holgado, E, Spigel, D, Waterhouse, D, Domine, M, Garassino, M, Chow, LQM, Blumenschein, G, Barlesi, F, Coudert, B, Gainor, J, Arrieta, O, Brahmer, J, Butts, C, Steins, M, Geese, WJ, Li, A, Healey, D, and Crinò, L. "Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases." Annals of Oncology : Official Journal of the European Society for Medical Oncology 29, no. 4 (April 2018): 959-965.  Full Text
    • Yang, C-FJ, McSherry, F, Mayne, NR, Wang, X, Berry, MF, Tong, B, Harpole, DH, D'Amico, TA, Christensen, JD, Ready, NE, and Klapper, JA. "Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer." The Annals of Thoracic Surgery 105, no. 3 (March 2018): 924-929.  Full Text
    • Faries, MB, Mozzillo, N, Kashani-Sabet, M, Thompson, JF, Kelley, MC, DeConti, RC, Lee, JE, Huth, JF, Wagner, J, Dalgleish, A, Pertschuk, D, Nardo, C, Stern, S, Elashoff, R, Gammon, G, Morton, DL, and MMAIT-IV Clinical Trial Group, . "Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases." Annals of Surgical Oncology 24, no. 13 (December 2017): 3991-4000.  Full Text
    • Horn, L, Spigel, DR, Vokes, EE, Holgado, E, Ready, N, Steins, M, Poddubskaya, E, Borghaei, H, Felip, E, Paz-Ares, L, Pluzanski, A, Reckamp, KL, Burgio, MA, Kohlhäeufl, M, Waterhouse, D, Barlesi, F, Antonia, S, Arrieta, O, Fayette, J, Crinò, L, Rizvi, N, Reck, M, Hellmann, MD, Geese, WJ, Li, A, Blackwood-Chirchir, A, Healey, D, Brahmer, J, and Eberhardt, WEE. "Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 35, no. 35 (December 2017): 3924-3933.  Full Text
    • Yi, JS, Ready, N, Healy, P, Dumbauld, C, Osborne, R, Berry, M, Shoemaker, D, Clarke, J, Crawford, J, Tong, B, Harpole, D, D'Amico, TA, McSherry, F, Dunphy, F, McCall, SJ, Christensen, JD, Wang, X, and Weinhold, KJ. "Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 23, no. 24 (December 2017): 7474-7482.  Full Text
    • Stinchcombe, TE, Zhang, Y, Vokes, EE, Schiller, JH, Bradley, JD, Kelly, K, Curran, WJ, Schild, SE, Movsas, B, Clamon, G, Govindan, R, Blumenschein, GR, Socinski, MA, Ready, NE, Akerley, WL, Cohen, HJ, Pang, HH, and Wang, X. "Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 35, no. 25 (September 2017): 2885-2892.  Full Text
    • Tandberg, DJ, Kelsey, CR, D'Amico, TA, Crawford, J, Chino, JP, Tong, BC, Ready, NE, and Wright, A. "Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall." Clinical Lung Cancer 18, no. 4 (July 2017): e259-e265.  Full Text
    • Zhou, F, Wang, Y, Liu, H, Ready, N, Han, Y, Hung, RJ, Brhane, Y, McLaughlin, J, Brennan, P, Bickeböller, H, Rosenberger, A, Houlston, RS, Caporaso, N, Landi, MT, Brüske, I, Risch, A, Ye, Y, Wu, X, Christiani, DC, Goodman, G, Chen, C, Transdisciplinary Research in Cancer of the Lung (TRICL) Research Team, , Amos, CI, and Wei, Q. "Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs." Molecular Carcinogenesis 56, no. 4 (April 2017): 1227-1238.  Full Text
    • Kelley, MJ, Jha, G, Shoemaker, D, Herndon, JE, Gu, L, Barry, WT, Crawford, J, and Ready, N. "Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer." Cancer Investigation 35, no. 1 (January 2017): 32-35.  Full Text
    • Rudin, CM, Pietanza, MC, Bauer, TM, Ready, N, Morgensztern, D, Glisson, BS, Byers, LA, Johnson, ML, Burris, HA, Robert, F, Han, TH, Bheddah, S, Theiss, N, Watson, S, Mathur, D, Vennapusa, B, Zayed, H, Lally, S, Strickland, DK, Govindan, R, Dylla, SJ, Peng, SL, Spigel, DR, and SCRX16-001 investigators, . "Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study." The Lancet. Oncology 18, no. 1 (January 2017): 42-51.  Full Text
    • Ryser, MD, Lee, WT, Ready, NE, Leder, KZ, and Foo, J. "Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach." Cancer Research 76, no. 24 (December 2016): 7078-7088.  Full Text
    • Boyer, MJ, Gu, L, Wang, X, Kelsey, CR, Yoo, DS, Onaitis, MW, Dunphy, FR, Crawford, J, Ready, NE, and Salama, JK. "Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer." Lung Cancer (Amsterdam, Netherlands) 98 (August 2016): 76-78.  Full Text
    • Wang, Y, Liu, H, Ready, NE, Su, L, Wei, Y, Christiani, DC, and Wei, Q. "Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients." International Journal of Cancer 138, no. 11 (June 2016): 2592-2601.  Full Text
    • Kelsey, CR, Christensen, JD, Chino, JP, Adamson, J, Ready, NE, and Perez, BA. "Adaptive planning using positron emission tomography for locally advanced lung cancer: A feasibility study." Practical Radiation Oncology 6, no. 2 (March 2016): 96-104.  Full Text
    • Salama, JK, Gu, L, Wang, X, Pang, HH, Bogart, JA, Crawford, J, Schild, SE, Vokes, EE, and Ready, NE. "Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE)." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 11, no. 3 (March 2016): 361-369.  Full Text
    • Roe, MT, Cyr, DD, Eckart, D, Schulte, PJ, Morse, MA, Blackwell, KL, Ready, NE, Zafar, SY, Beaven, AW, Strickler, JH, Onken, JE, Winters, KJ, Houterloot, L, Zamoryakhin, D, Wiviott, SD, White, HD, Prabhakaran, D, Fox, KAA, Armstrong, PW, Ohman, EM, and TRILOGY ACS Investigators, . "Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome." European Heart Journal 37, no. 4 (January 2016): 412-422.  Full Text
    • Clarke, JM, Wang, X, and Ready, NE. "Surrogate clinical endpoints to predict overall survival in non-small cell lung cancer trials-are we in a new era?." Translational Lung Cancer Research 4, no. 6 (December 2015): 804-808.  Full Text
    • Kelsey, CR, Das, S, Gu, L, Dunphy, FR, Ready, NE, and Marks, LB. "Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer." International Journal of Radiation Oncology, Biology, Physics 93, no. 5 (December 2015): 997-1004.  Full Text
    • Borghaei, H, Paz-Ares, L, Horn, L, Spigel, DR, Steins, M, Ready, NE, Chow, LQ, Vokes, EE, Felip, E, Holgado, E, Barlesi, F, Kohlhäufl, M, Arrieta, O, Burgio, MA, Fayette, J, Lena, H, Poddubskaya, E, Gerber, DE, Gettinger, SN, Rudin, CM, Rizvi, N, Crinò, L, Blumenschein, GR, Antonia, SJ, Dorange, C, Harbison, CT, Graf Finckenstein, F, and Brahmer, JR. "Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer." The New England Journal of Medicine 373, no. 17 (October 2015): 1627-1639.  Full Text
    • Brahmer, J, Reckamp, KL, Baas, P, Crinò, L, Eberhardt, WEE, Poddubskaya, E, Antonia, S, Pluzanski, A, Vokes, EE, Holgado, E, Waterhouse, D, Ready, N, Gainor, J, Arén Frontera, O, Havel, L, Steins, M, Garassino, MC, Aerts, JG, Domine, M, Paz-Ares, L, Reck, M, Baudelet, C, Harbison, CT, Lestini, B, and Spigel, DR. "Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer." The New England Journal of Medicine 373, no. 2 (July 2015): 123-135.  Full Text
    • Ready, NE, Pang, HH, Gu, L, Otterson, GA, Thomas, SP, Miller, AA, Baggstrom, M, Masters, GA, Graziano, SL, Crawford, J, Bogart, J, and Vokes, EE. "Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 33, no. 15 (May 2015): 1660-1665.  Full Text
    • Pepek, JM, Marks, LB, Berry, MF, Ready, NE, Gee, NG, Coleman, RE, D'Amico, TA, Crawford, J, and Kelsey, CR. "Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy." Practical radiation oncology 5, no. 2 (March 2015): 79-84.  Full Text
    • Pepek, JM, Marks, LB, Berry, MF, Ready, NE, Gee, NG, Coleman, RE, D'Amico, TA, Crawford, J, and Kelsey, CR. "Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy." Practical Radiation Oncology 5, no. 2 (March 1, 2015): 79-84.  Full Text
    • Boyle, JM, Tandberg, DJ, Chino, JP, D'Amico, TA, Ready, NE, and Kelsey, CR. "Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis." Cancer 121, no. 4 (February 2015): 598-604.  Full Text
    • Uronis, HE, Jia, J, Bendell, JC, Howard, L, Ready, NA, Lee, PH, Starr, MD, Dellinger, A, Pang, H, Nixon, AB, and Hurwitz, HI. "A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors." Cancer chemotherapy and pharmacology 75, no. 2 (February 2015): 343-352.  Full Text
    • Uronis, HE, Jia, J, Bendell, JC, Howard, L, Ready, NA, Lee, PH, Starr, MD, Dellinger, A, Pang, H, Nixon, AB, and Hurwitz, HI. "A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors." Cancer Chemotherapy and Pharmacology 75, no. 2 (January 1, 2015): 343-352.  Full Text
    • Stevenson, M, Christensen, J, Shoemaker, D, Foster, T, Barry, WT, Tong, BC, Wahidi, M, Shofer, S, Datto, M, Ginsburg, G, Crawford, J, D'Amico, T, and Ready, N. "Tumor acquisition for biomarker research in lung cancer." Cancer investigation 32, no. 6 (July 2014): 291-298.  Full Text
    • Denehy, L, Hornsby, WE, Herndon, JE, Thomas, S, Ready, NE, Granger, CL, Valera, L, Kenjale, AA, Eves, ND, and Jones, LW. "Prognostic Validation of the Body Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity (BODE) Index in Inoperable Non-Small-Cell Lung Cancer." JOURNAL OF THORACIC ONCOLOGY 8, no. 12 (December 2013): 1545-1550.  Full Text  Link to Item
    • Tandberg, DJ, Gee, NG, Chino, JP, D'Amico, TA, Ready, NE, Coleman, RE, and Kelsey, CR. "Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?." J Thorac Cardiovasc Surg 146, no. 4 (October 2013): 796-801.  Full Text  Link to Item
    • Tandberg, DJ, Gee, NG, Chino, JP, D’Amico, TA, Ready, NE, Coleman, RE, and Kelsey, CR. "Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant?." The Journal of Thoracic and Cardiovascular Surgery 146, no. 4 (October 2013): 796-801.  Full Text
    • Washington, I, Chino, JP, Marks, LB, D'Amico, TA, Berry, MF, Ready, NE, Higgins, KA, Yoo, DS, and Kelsey, CR. "Diabetes mellitus: A significant co-morbidity in the setting of lung cancer?." THORACIC CANCER 4, no. 2 (May 2013): 123-130.  Full Text  Link to Item
    • Kalemkerian, GP, Akerley, W, Bogner, P, Borghaei, H, Chow, LQ, Downey, RJ, Gandhi, L, Ganti, AKP, Govindan, R, Grecula, JC, Hayman, J, Heist, RS, Horn, L, Jahan, T, Koczywas, M, Loo, BW, Merritt, RE, Moran, CA, Niell, HB, O'Malley, J, Patel, JD, Ready, N, Rudin, CM, Williams, CC, Gregory, K, Hughes, M, and National Comprehensive Cancer Network, . "Small cell lung cancer." Journal of the National Comprehensive Cancer Network : Jnccn 11, no. 1 (January 2013): 78-98.  Full Text
    • Roe, MT, Armstrong, PW, Fox, KAA, White, HD, Prabhakaran, D, Goodman, SG, Cornel, JH, Bhatt, DL, Clemmensen, P, Martinez, F, Ardissino, D, Nicolau, JC, Boden, WE, Gurbel, PA, Ruzyllo, W, Dalby, AJ, McGuire, DK, Leiva-Pons, JL, Parkhomenko, A, Gottlieb, S, Topacio, GO, Hamm, C, Pavlides, G, Goudev, AR, Oto, A, Tseng, C-D, Merkely, B, Gasparovic, V, Corbalan, R, Cinteză, M, McLendon, RC, Winters, KJ, Brown, EB, Lokhnygina, Y, Aylward, PE, Huber, K, Hochman, JS, Ohman, EM, and TRILOGY ACS Investigators, . "Prasugrel versus clopidogrel for acute coronary syndromes without revascularization." The New England Journal of Medicine 367, no. 14 (October 2012): 1297-1309.  Full Text
    • Higgins, KA, Chino, JP, Ready, N, D'Amico, TA, Berry, MF, Sporn, T, Boyd, J, and Kelsey, CR. "Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy." J Thorac Oncol 7, no. 7 (July 2012): 1141-1147.  Full Text  Link to Item
    • Vlahovic, G, Meadows, KL, Uronis, HE, Morse, MA, Blobe, GC, Riedel, RF, Zafar, SY, Alvarez-Secord, A, Gockerman, J, Starodub, AN, Ready, NE, Anderson, EL, Bendell, JC, and Hurwitz, HI. "A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors." Cancer Chemotherapy and Pharmacology 70, no. 1 (July 2012): 95-102.  Full Text
    • Cuneo, KC, Zagar, TM, Brizel, DM, Yoo, DS, Hoang, JK, Chang, Z, Wang, Z, Yin, FF, Das, SK, Green, S, Ready, N, Bhatti, MT, Kaylie, DM, Becker, A, Sampson, JH, and Kirkpatrick, JP. "Stereotactic radiotherapy for malignancies involving the trigeminal and facial nerves." Technology in Cancer Research & Treatment 11, no. 3 (June 2012): 221-228.  Full Text
    • Higgins, KA, Chino, JP, Berry, M, Ready, N, Boyd, J, Yoo, DS, and Kelsey, CR. "Local failure in resected N1 lung cancer: implications for adjuvant therapy." Int J Radiat Oncol Biol Phys 83, no. 2 (June 1, 2012): 727-733.  Full Text  Link to Item
    • Lee, WT, Yoo, DS, Puscas, L, Witsell, D, Cohen, SM, Fisher, SR, Scher, R, Broadwater, G, Ready, N, Brizel, DR, and Esclamado, RM. "Treatment-induced changes in vocal cord mobility and subsequent local recurrence after organ preservation therapy for laryngeal carcinoma." Head Neck 34, no. 6 (June 2012): 792-796.  Full Text  Link to Item
    • Yoo, DS, Kirkpatrick, JP, Craciunescu, O, Broadwater, G, Peterson, BL, Carroll, MD, Clough, R, MacFall, JR, Hoang, J, Scher, RL, Esclamado, RM, Dunphy, FR, Ready, NE, and Brizel, DM. "Prospective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancer." Clin Cancer Res 18, no. 5 (March 1, 2012): 1404-1414.  Full Text  Link to Item
    • Ready, NE, Rathore, R, Johnson, TT, Nadeem, A, Chougule, P, Ruhl, C, Radie-Keane, K, Theall, K, Wanebo, HJ, Marcello, J, and Kennedy, T. "Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck." American Journal of Clinical Oncology 35, no. 1 (February 2012): 6-12.  Full Text
    • Higgins, KA, Chino, JP, Ready, N, Onaitis, MW, Berry, MF, D'Amico, TA, and Kelsey, CR. "Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer." J Thorac Cardiovasc Surg 142, no. 5 (November 2011): 1175-1179.  Full Text  Link to Item
    • Ready, NE, Dudek, AZ, Pang, HH, Hodgson, LD, Graziano, SL, Green, MR, and Vokes, EE. "Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 29, no. 33 (November 2011): 4436-4441.  Full Text
    • Pepek, JM, Chino, JP, Marks, LB, D'amico, TA, Yoo, DS, Onaitis, MW, Ready, NE, Hubbs, JL, Boyd, J, and Kelsey, CR. "How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems." J Thorac Oncol 6, no. 4 (April 2011): 757-761.  Full Text  Link to Item
    • Ready, N, Karaseva, NA, Orlov, SV, Luft, AV, Popovych, O, Holmlund, JT, Wood, BA, and Leopold, L. "Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 6, no. 4 (April 2011): 781-785.  Full Text
    • Ahmed, S, Birnbaum, AE, Safran, HP, Dipetrillo, TA, Aswad, BI, Ready, NE, and Ng, T. "Pathologic response after neoadjuvant carboplatin and weekly paclitaxel for early-stage lung cancer: A Brown University Oncology Group phase II study." Journal of Thoracic Oncology 6, no. 8 (2011): 1432-1434.  Full Text
    • Kalemkerian, GP, Akerley, W, Rogner, P, Borghaei, H, Chow, L, Downey, RJ, Gandhi, L, Ganti, AKP, Govindan, R, Grecula, JC, Hayman, J, Heist, RS, Horn, L, Jahan, TM, Koczywas, M, Moran, CA, Niell, HD, O'Malley, J, Patel, JD, Ready, N, Rudin, CM, and Jr, CCW. "Small cell lung cancer clinical practice guidelines in oncology." JNCCN Journal of the National Comprehensive Cancer Network 9, no. 10 (2011): 1086-1113.
    • Wanebo, HJ, Rathore, R, Chougule, P, Disiena, MR, Koness, RJ, McRae, RG, Nigri, PT, Radie-Keane, K, and Ready, N. "Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: Long-term results of two sequential brown university oncology group chemoradiotherapy studies." Annals of Surgical Oncology 18, no. 12 (2011): 3479-3485.  Full Text
    • Rathore, R, Birnbaum, A, Rathore, B, DiPetrillo, T, Kennedy, T, and Ready, N. "Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93)." Cancer Chemotherapy and Pharmacology 66, no. 6 (November 2010): 1013-1017.  Full Text
    • Ready, N, Jänne, PA, Bogart, J, Dipetrillo, T, Garst, J, Graziano, S, Gu, L, Wang, X, Green, MR, Vokes, EE, Cancer, Leukemia Group B, Chicago, and IL, . "Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 5, no. 9 (September 2010): 1382-1390.  Full Text
    • Birnbaum, A, Dipetrillo, T, Rathore, R, Anderson, E, Wanebo, H, Puthwala, Y, Joyce, D, Safran, H, Henderson, D, Kennedy, T, Ready, N, and Sio, TT-W. "Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: A toxicity analysis." American Journal of Clinical Oncology: Cancer Clinical Trials 33, no. 2 (2010): 144-147.  Full Text
    • Stevenson, M, Mostertz, W, Acharya, C, Kim, W, Walters, K, Barry, W, Higgins, K, Tuchman, SA, Crawford, J, Vlahovic, G, Ready, N, Onaitis, M, and Potti, A. "Characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma." Clin Cancer Res 15, no. 24 (December 15, 2009): 7553-7561.  Full Text  Link to Item
    • Higgins, K, Chino, JP, Marks, LB, Ready, N, D'Amico, TA, Clough, RW, and Kelsey, CR. "Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer." Int J Radiat Oncol Biol Phys 75, no. 5 (December 1, 2009): 1462-1467.  Full Text  Link to Item
    • Kelsey, CR, Marks, LB, Hollis, D, Hubbs, JL, Ready, NE, D'Amico, TA, and Boyd, JA. "Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients." Cancer 115, no. 22 (November 2009): 5218-5227.  Full Text
    • Hirsh, R, Giri, D, Griffith, R, Stone, R, and Ready, N. "Langerhans cell histiocytosis following acute leukemia in an adult." American Journal of Hematology 84, no. 10 (2009): 693-694.  Full Text
    • Zhu, AX, Ready, N, Clark, JW, Safran, H, Amato, A, Salem, N, Pace, S, He, X, Zvereva, N, Lynch, TJ, Ryan, DP, and Supko, JG. "Phase I and Pharmacokinetic study of gimatecan given orally once a week for 3 of 4 weeks in Patients with advanced solid tumors." Clinical Cancer Research 15, no. 1 (2009): 374-381.  Full Text
    • Chougule, PB, Akhtar, MS, Rathore, R, Koness, J, McRae, R, Nigri, P, Radie-Keane, K, Kennedy, T, Wanebo, HJ, and Ready, N. "Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group phase II study (HN-53)." Head and Neck 30, no. 3 (2008): 289-296.  Full Text
    • Kalemkerian, GP, Akerley, W, Downey, RJ, Ettinger, DS, Fossella, F, Grecula, JC, Jahan, T, Johnson, BE, Kessinger, A, Koczywas, M, Langer, CJ, Martins, R, Niell, HB, Pan, CC, Ramnath, N, Ready, N, Robert, F, and Jr, CCW. "Small cell lung cancer." JNCCN Journal of the National Comprehensive Cancer Network 6, no. 3 (2008): 294-314.
    • Grieco, CA, Simon, CJ, Mayo-Smith, WW, Dipetrillo, TA, Ready, NE, and Dupuy, DE. "Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses." American Journal of Clinical Oncology: Cancer Clinical Trials 30, no. 4 (2007): 361-367.  Full Text
    • Ready, NE, Lipton, A, Zhu, Y, Statkevich, P, Frank, E, Curtis, D, and Bukowski, RM. "Phase I study of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid tumors." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 13, no. 2 Pt 1 (January 2007): 576-583.  Full Text
    • Shah, C, Ready, N, Perry, M, Kirshner, J, Gajra, A, Neuman, N, and Garziano, S. "A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer." Lung Cancer 57, no. 1 (2007): 84-88.  Full Text
    • Akerley, W, Safran, H, Zaner, K, Ready, N, Mega, T, and Kennedy, T. "Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, Stage IIIB-IV nonsmall cell lung cancer." Cancer 107, no. 5 (2006): 1050-1054.  Full Text
    • Dupuy, DE, DiPetrillo, T, Gandhi, S, Ready, N, Ng, T, Donat, W, and Mayo-Smith, WW. "Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer." Chest 129, no. 3 (2006): 738-745.  Full Text
    • Grieco, CA, Simon, CJ, Mayo-Smith, WW, DiPetrillo, TA, Ready, NE, and Dupuy, DE. "Percutaneous image-guided thermal ablation and radiation therapy: Outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer." Journal of Vascular and Interventional Radiology 17, no. 7 (2006): 1117-1124.  Full Text
    • Ready, N, Aronson, F, Wanebo, H, and Kennedy, T. "A low rate of central nervous system progression in a phase II trial of outpatient chemobiologic therapy with cisplatin, temozolomide, interleukin-2, and interferon alfa 2-B for metastatic malignant melanoma." American Journal of Clinical Oncology 28, no. 5 (October 2005): 479-484.  Full Text
    • Ready, N. "Inhibition of the epidermal growth factor receptor in combined modality treatment for locally advanced non-small cell lung cancer." Seminars in Oncology 32, no. 2 Suppl 3 (April 2005): S35-S41. (Review)  Full Text
    • Birnbaum, A, and Ready, N. "Gefitinib therapy for non-small cell lung cancer." Current Treatment Options in Oncology 6, no. 1 (January 2005): 75-81. (Review)  Full Text
    • Ready, NE, and Vokes, EE. "Induction or consolidation systemic therapy in the multimodality treatment of unresectable locally advanced non-small cell lung cancer." Lung Cancer (Amsterdam, Netherlands) 42 Suppl 1 (December 2003): S65-S69. (Review)  Full Text
    • Ready, N, and Weinstock, MA. "Elective lymph node dissection for melanoma laid to rest yet again." Archives of Dermatology 139, no. 9 (September 1, 2003): 1203-1204.  Full Text
    • Cox, JD, Chevalier, TL, Arriagada, R, Choy, H, Curran, WJ, Fukuoka, M, Harper, P, Komaki, R, Pechoux, CL, Lievens, Y, Rami-Porta, R, Ready, N, Sause, W, Stuschke, M, and Thatcher, N. "Management of unresectable non-small cell carcinoma of the lung (NSCLC)." Lung Cancer 42, no. 2 SUPPL. (2003): S15-S16.  Full Text
    • Postmus, PE, Rocmans, P, Asamura, H, Ball, D, Belderbos, J, Cappello, M, Jassem, J, Novello, S, Pass, H, Passlick, B, Pirker, R, Ready, N, Sause, W, Scagliotti, G, Vansteenkiste, J, Westeel, V, and Zandwijk, NV. "Consensus report IASLC workshop Bruges, September 2002: Pretreatment minimal staging for non-small cell lung cancer." Lung Cancer 42, no. 2 SUPPL. (2003): S3-S6.  Full Text
    • Ready, N, and Weinstock, MA. "Adjuvant High-Dose Interferon Therapy for High-Risk Melanoma." Archives of Dermatology 139, no. 12 (2003): 1635-1637.  Full Text
    • Akerley, W, Rathore, R, Ready, N, Leone, L, Sikov, W, Safran, H, and Kennedy, T. "A phase I study of a weekly schedule of paclitaxel and carboplatin in patients with advanced carcinoma." Cancer 95, no. 9 (2002): 2000-2005.  Full Text
    • Moore, T, and Ready, N. "Update in non-small cell lung cancer." Medicine and health, Rhode Island 85, no. 1 (2002): 7-9.
    • Wanebo, H, Chougule, P, Ready, N, Safran, H, Ackerley, W, Koness, RJ, McRae, R, Nigri, P, Leone, L, Radie-Keane, K, Reiss, P, and Kennedy, T. "Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV)." Annals of Surgical Oncology 8, no. 8 (2001): 644-650.  Full Text
    • Chougule, PB, Akhtar, MS, Akerley, W, Ready, N, Safran, H, McRae, R, Nigri, P, Bellino, J, Koness, J, Radie-Keane, K, and Wanebo, H. "Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study." Seminars in Radiation Oncology 9, no. 2 SUPPL. 1 (1999): 58-63.
    • Wanebo, HJ, Chougule, P, Ready, N, Koness, RJ, Akerley, W, McRae, R, Nigri, P, Leone, L, Webber, B, and Safran, H. "Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV)." Seminars in Radiation Oncology 9, no. 2 SUPPL. 1 (1999): 77-84.
    • Kluger, NJ, Cummings, FJ, Ready, NE, Sweeney, JD, and Weitberg, AB. "Post transfusion non-cardiogenic pulmonary edema in a patient with chemotherapy-related hemolytic uremic syndrome." Medicine and health, Rhode Island 81, no. 7 (1998): 235-236.
    • Chougule, P, Wanebo, H, Akerley, W, McRae, R, Nigri, P, Leone, L, Safran, H, Ready, N, Koness, RJ, Radie-Keane, K, and Cole, B. "Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: A phase II study - Preliminary results." Seminars in Oncology 24, no. 6 SUPPL. 19 (1997): S19-57-S19-61-.
    • Wanebo, HJ, Chougule, P, III, WLA, Koness, RJ, McRae, R, Nigri, P, Leone, L, Ready, N, Safran, H, Webber, B, and Cole, B. "Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer." American Journal of Surgery 174, no. 5 (1997): 518-522.  Full Text
    • Celi, A, Pellegrini, G, Lorenzet, R, De Blasi, A, Ready, N, Furie, BC, and Furie, B. "P-selectin induces the expression of tissue factor on monocytes." Proceedings of the National Academy of Sciences of the United States of America 91, no. 19 (September 1994): 8767-8771.  Full Text
    • Ready, N, Freeman, NJ, and Carvalho, A. "Treatment choices in chronic myelogenous leukemia." Hospital Practice 27, no. 9 A (1992): 95-98+101.
    • Mizisin, AP, and Ready, NE. "Growth and development of flight muscle in the locust (Schistocerca nitens, Thünberg)." Journal of Experimental Zoology 237, no. 1 (January 1, 1986): 45-55.  Full Text
    • Ready, NE. "Development of fast singing muscles in a katydid." The Journal of experimental zoology 238, no. 1 (1986): 43-54.
    • "Structural and functional development of cricket wing muscles." Journal of Experimental Zoology 233, no. 1 (January 1, 1985): 3550-null.
    • Ready, NE, and Najm, RE. "Structural and functional development of cricket ring muscles." Journal of Experimental Zoology 233, no. 1 (1985): 35-50.
    • Ready, NE, and Josephson, RK. "Flight muscle development in a hemimetabolous insect." Journal of Experimental Zoology 220, no. 1 (March 1, 1982): 49-56.  Full Text
    • Oglesby, LC, Mangum, CP, Heacox, AE, and Ready, NE. "Salt and water balance in the polychaete Nereis virens." Comparative Biochemistry and Physiology Part A: Physiology 73, no. 1 (January 1982): 15-19.  Full Text

  • Other Articles

    • Stevenson, M, Mostertz, W, Acharya, CR, Kim, W, Walters, K, Barry, W, Higgins, K, Tuchman, SA, Crawford, J, Vlahovic, G, Ready, N, Onaitis, M, and Potti, A. "Retraction: characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma." Clin Cancer Res 18, no. 6 (March 15, 2012): 1818-.  Full Text  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.